Alnylam Pharmaceuticals (ALNY) Interest Coverage Ratio (2020 - 2026)
Alnylam Pharmaceuticals (ALNY) reported Interest Coverage Ratio of 3.88 for Q1 2026, up 1150.63% on a YoY basis from 0.31 in Q1 2025, and up 92.51% quarter-over-quarter from 2.01 in Q4 2025.
Alnylam Pharmaceuticals (ALNY) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Alnylam Pharmaceuticals has reported Interest Coverage Ratio for 7 years, with the latest figure at 3.88 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 1150.63% year-over-year to 3.88; the trailing twelve-month figure through Mar 2026 stood at 3.43 (up 590.18% YoY), and the FY2025 full-year result was 1.99, up 259.23% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 3.88, up from 2.01 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 8.29 in Q3 2025, with the low at 7.65 in Q2 2023.
- Historically, Interest Coverage Ratio has averaged 1.22 across 5 years, with a median of 2.24 in 2024.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio sank 132.32% — and 2026, when it surged 1150.63%.
- Alnylam Pharmaceuticals' Interest Coverage Ratio stood at 6.31 in 2022, then soared by 41.09% to 3.71 in 2023, then grew by 27.35% to 2.7 in 2024, then soared by 174.64% to 2.01 in 2025, then jumped by 92.51% to 3.88 in 2026.
- The last three Interest Coverage Ratio figures came in at 3.88 (Q1 2026), 2.01 (Q4 2025), and 8.29 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Alnylam Pharmaceuticals | 37.04 Bn | 34.03 Bn | 959.66 Mn | 3.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.88 |
| Dec 31, 2025 | 2.01 |
| Sep 30, 2025 | 8.29 |
| Jun 30, 2025 | -0.40 |
| Mar 31, 2025 | 0.31 |
| Dec 31, 2024 | -2.70 |
| Sep 30, 2024 | -2.24 |
| Jun 30, 2024 | 1.46 |
| Mar 31, 2024 | -1.23 |
| Dec 31, 2023 | -3.71 |
| Sep 30, 2023 | 6.92 |
| Jun 30, 2023 | -7.65 |
| Mar 31, 2023 | -5.17 |
| Dec 31, 2022 | -6.31 |
| Sep 30, 2022 | -6.28 |
| Jun 30, 2022 | -4.50 |
| Mar 31, 2022 | -3.46 |
| Dec 31, 2021 | -5.28 |
| Sep 30, 2021 | -4.51 |
| Jun 30, 2021 | -4.37 |